Table 3

Association between MC and genital HPV detection in men by lifetime number of female partners
Circumcision
N No Yes
Univariate Multivariable1
PR (95% CI) PR (95% CI)
Any HPV
 Lifetime number of female partners P = 0.1462
  1-4 1099 1.00 0.97 (0.87-1.08) 0.92 (0.81-1.03)
  5-12 1183 1.00 0.98 (0.91-1.07) 0.96 (0.88-1.05)
  13+ 1083 1.00 1.03 (0.97-1.10) 1.03 (0.96-1.10)
Oncogenic HPV
 Lifetime number of female partners P = 0.2042
  1-4 667 1.00 0.93 (0.73 - 1.19) 0.96 (0.73 - 1.26)
  5-12 726 1.00 0.96 (0.82 - 1.12) 0.92 (0.77 - 1.09)
  13+ 697 1.00 1.06 (0.95 - 1.18) 1.06 (0.95 - 1.19)
Non-Oncogenic HPV
 Lifetime number of female partners P = 0.0062
  1-4 647 1.00 0.62 (0.45 - 0.83) 0.59 (0.42 - 0.83)
  5-12 668 1.00 0.89 (0.74 - 1.07) 0.88 (0.72 - 1.08)
  13+ 542 1.00 1.03 (0.88 - 1.20) 1.03 (0.88 - 1.21)
Unclassified HPV
 Lifetime number of female partners P = 0.9522
  1-4 717 1.00 1.24 (1.01 – 1.51) 1.03 (0.82 – 1.28)3
  5-12 527 1.00 1.25 (0.96 – 1.61) 1.15 (0.86 – 1.53)3
  13+ 330 1.00 1.19 (0.83 – 1.71) 1.10 (0.74 – 1.62)3

NOTE.PR, prevalence ratio; CI, confidence interval. Numbers in bold correspond to statistically significant point estimates.

1Adjusted for race, marital status, female sexual partners in past 3–6 months and male anal sexual partners in the past 3 months.

2Test for interaction between MC and lifetime number of female partners.

3Adjusted for race, marital status, and male anal sexual partners in the past 3 months.

Albero et al.

Albero et al. BMC Infectious Diseases 2013 13:18   doi:10.1186/1471-2334-13-18

Open Data